Literature DB >> 7477445

Enhancement of adenosine A1 receptor functions by benzoylthiophenes in guinea pig tissues in vitro.

E Leung1, L K Walsh, L A Flippin, E J Kim, D A Lazar, C S Seran, E H Wong, R M Eglen.   

Abstract

Previous reports on a series of benzoylthiophenes, including PD 81,723 [2-amino-4,5-dimethyl-3-(3-trifluoromethyl-benzoyl) thiophene], have shown specific enhancement of agonist binding at the adenosine A1 receptor. We have studied the effects of two substituted benzoylthiophenes, PD 78,416 (thieno[2,3-c]pyridine-6(5H)-carboxylic acid, 2-amino-3-benzoyl-4,7-dihydro-ethyl ester) and RS-74513-000 [2-amino-4-ethyl-5-methyl-3-(3-trifluoro-methyl-benzoyl) thiophene] on response elicited by adenosine A1 receptors in isolated guinea pig left atrium and ileum. In the electrically paced left atrium, PD 78,416 antagonized negative inotropic effect elicited by the agonist CPA [N6-cyclopentyladenosine] with a pKB value of 6.2 +/- 0.2 (n = 4). At a low concentration which had no antagonistic effect (0.1 microM), PD 78,416 enhanced the effect of CPA. The concentration-response curve to CPA was shifted leftward by 5.1 fold (95% confidence limits 2.4-11.2). In field stimulated isolated ileum, PD 78,416 (0.1, 0.3, 1 microM) did not enhance or antagonize effects of CPA. At concentrations above 1 microM, PD 78,416 decreased electrically induced contraction. This effect was not sensitive to adenosine deaminase and was not antagonized by the A1 antagonist CPX [8-cyclopentyl-1,3-dipropyl-xanthine] (1 microM). Unlike PD 78,416, RS-74513-000 (0.01, 0.1, 1, 3, 10 microM) did not antagonize or enhance effects of CPA in the left atrium. However, effects of CPA in ileum were enhanced by RS-74513-000 (1 and 3 microM).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7477445     DOI: 10.1007/bf00176776

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  13 in total

1.  Cardiac nucleotides in hypoxia: possible role in regulation of coronary blood flow.

Authors:  R M BERNE
Journal:  Am J Physiol       Date:  1963-02

2.  Functional activity of the adenosine binding enhancer, PD 81,723, in the in vitro hippocampal slice.

Authors:  C A Janusz; R F Bruns; R F Berman
Journal:  Brain Res       Date:  1991-12-20       Impact factor: 3.252

Review 3.  The physiological role of adenosine in the central nervous system.

Authors:  T V Dunwiddie
Journal:  Int Rev Neurobiol       Date:  1985       Impact factor: 3.230

4.  Synergistic activation of a G protein-coupled receptor kinase by G protein beta gamma subunits and mastoparan or related peptides.

Authors:  K Haga; K Kameyama; T Haga
Journal:  J Biol Chem       Date:  1994-04-29       Impact factor: 5.157

5.  Increased adenosine concentration in blood from ischemic myocardium by AICA riboside. Effects on flow, granulocytes, and injury.

Authors:  H E Gruber; M E Hoffer; D R McAllister; P K Laikind; T A Lane; G W Schmid-Schoenbein; R L Engler
Journal:  Circulation       Date:  1989-11       Impact factor: 29.690

Review 6.  Adenosine, the heart, and coronary circulation.

Authors:  M Hori; M Kitakaze
Journal:  Hypertension       Date:  1991-11       Impact factor: 10.190

7.  Selective potentiation by an A1 adenosine receptor enhancer of the negative dromotropic action of adenosine in the guinea pig heart.

Authors:  B Amoah-Apraku; J Xu; J Y Lu; A Pelleg; R F Bruns; L Belardinelli
Journal:  J Pharmacol Exp Ther       Date:  1993-08       Impact factor: 4.030

8.  The adenosine binding enhancer, PD 81,723, inhibits epileptiform bursting in the hippocampal brain slice.

Authors:  C A Janusz; R F Berman
Journal:  Brain Res       Date:  1993-08-13       Impact factor: 3.252

Review 9.  Harnessing nature's own cardiac defense mechanism with acadesine, an adenosine regulating agent: importance of the endothelium.

Authors:  R L Engler
Journal:  J Card Surg       Date:  1994-05       Impact factor: 1.620

Review 10.  Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential.

Authors:  K A Jacobson; P J van Galen; M Williams
Journal:  J Med Chem       Date:  1992-02-07       Impact factor: 7.446

View more
  1 in total

Review 1.  Allosteric modulation of purine and pyrimidine receptors.

Authors:  Kenneth A Jacobson; Zhan-Guo Gao; Anikó Göblyös; Adriaan P Ijzerman
Journal:  Adv Pharmacol       Date:  2011
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.